Promising new treatment for rare sugar disorder moves to final testing phase
NCT ID NCT06208215
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests an investigational drug called RZ358 for people with congenital hyperinsulinism, a rare condition causing dangerously low blood sugar. The trial involves 56 participants aged 3 months to 45 years who still have low blood sugar despite standard treatments. Over 24 weeks, half will receive RZ358 plus standard care, and half will receive a placebo plus standard care, to see if the drug reduces low blood sugar events safely.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CONGENITAL HYPERINSULINISM are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Children's Hospital of Philadelphia
Philadelphia, Pennsylvania, 19104, United States
-
Cook Children's Medical Center
Fort Worth, Texas, 76104, United States
-
Rezolute Investigative Site, Al Rayyan, Qatar
Al Rayyan, Qatar
-
Rezolute Investigative Site, Ankara, Turkey
Ankara, 06800, Turkey (Türkiye)
-
Rezolute Investigative Site, Athens, Greece
Athens, 115 27, Greece
-
Rezolute Investigative Site, Barcelona, Spain
Barcelona, 08035, Spain
-
Rezolute Investigative Site, Berlin, Germany
Berlin, 13353, Germany
-
Rezolute Investigative Site, Bron, France
Bron, 69677, France
-
Rezolute Investigative Site, Dusseldorf, Germany
Düsseldorf, 40225, Germany
-
Rezolute Investigative Site, Hà Nội, Vietnam
Hà Nội, 100000, Vietnam
-
Rezolute Investigative Site, London, United Kingdom
London, WC1N 3JH, United Kingdom
-
Rezolute Investigative Site, Manchester, United Kingdom
Manchester, M13 9WL, United Kingdom
-
Rezolute Investigative Site, Odense, Denmark
Odense, 5000, Denmark
-
Rezolute Investigative Site, Paris, France
Paris, 75015, France
-
Rezolute Investigative Site, Seeb, Oman
Seeb, 123, Oman
-
Rezolute Investigative Site, Sevilla, Spain
Seville, 41013, Spain
-
Rezolute Investigative Site, Tbilisi, Georgia
Tbilisi, 0159, Georgia
-
Rezolute Investigative Site, Varna, Bulgaria
Varna, 9010, Bulgaria